Market Cap
$2.0B
MRVI
MARAVAI LIFESCIENCES HOLDINGS, INC.
$7.90 ▲ +5.33%
Prev close $7.50Market cap$2.0B
ConsensusBuy
12-mo target$7.60 (-3.8%)
▲ Bullish
Analyst conviction 7/10
24 New Institutional Positions11 Institutional Exits Biotech & Drug Discovery
Snapshot
The big-picture read on MRVI right now — valuation, ownership and activity at a glance.
Cap Size
Small Cap
Analyst Consensus
Buy (67%)
Inst. Holders
50 funds
Inst. Value
$492.3M
Inst. Activity
24 buys / 11 sells
Insider Activity
$0.00 buy / $254.0K sell
Insider Net $
-$254.0K
SEC Reports
4
Price chart 30d +7.2%
Daily candles (open–high–low–close) with volume. Green = up day, red = down day.
No data for this timeframe.
Vol
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Sep 30, 2026 Insider
Asarpota Rajesh surrendered for taxes 5,465 shares
Chief Financial Officer @ $7.65 ($41.8K)
Sep 8, 2026 Insider
Brust Bernd surrendered for taxes 29,250 shares
Chief Executive Officer @ $7.32 ($214.1K)
Aug 31, 2026 Insider
Asarpota Rajesh surrendered for taxes 5,465 shares
Chief Financial Officer @ $7.68 ($42.0K)
Aug 10, 2026 short_volume
Short Volume: MRVI — 71.5% short (0.5M / 0.6M)
Short: 451,752 | Exempt: 3,930 | TRF Vol: 631,871 | Short Ratio: 71.5% | Off-exchange volume (dark p
Jun 30, 2026 Inst.
MILLENNIUM MANAGEMENT LLC — DOUBLED
6,508,220 shares ($40.6M)
Jun 30, 2026 Inst.
Jun 14, 2026 SEC DEUTSCHE BANK AG\ — DOUBLED
4,304,927 shares ($26.9M)
During Q1 2026, six institutional investors increased their MRVI positions (net +$2.3M) while three trimmed (net -$256K)
INST-CLUSTER — Impact 4/10
Maravai LifeSciences refinanced its prior credit agreement by entering into a new $150.0 million term loan and $30.0 mil
8-K — Impact 6/10
Analyst ratings buy % +13.6%
How Wall Street rates the stock today, and the latest firm-by-firm actions.
67% rate it Buy or better · 15 analysts
Recent analyst actions
| Date | Firm | Action | Rating | Firm rating |
|---|---|---|---|---|
| Sep 9, 2026 | UBS | MAINTAIN | Neutral | 55% |
| Aug 7, 2026 | Wells Fargo | MAINTAIN | Overweight | 54% |
| May 8, 2026 | Wells Fargo | MAINTAIN | Overweight | 54% |
Monthly consensus history
| Period | Str. Buy | Buy | Hold | Sell | Str. Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | 4 | 6 | 5 | 0 | 0 | 67% | |
| Aug 1, 2026 | 4 | 6 | 5 | 0 | 0 | 67% | |
| Jul 1, 2026 | 4 | 6 | 5 | 0 | 0 | 67% | |
| Jun 1, 2026 | 4 | 6 | 6 | 0 | 0 | 63% | |
| May 1, 2026 | 4 | 6 | 6 | 0 | 0 | 63% | |
| Apr 1, 2026 | 4 | 6 | 7 | 0 | 0 | 59% | |
| Mar 1, 2026 | 4 | 6 | 7 | 0 | 0 | 59% | |
| Feb 1, 2026 | 4 | 6 | 7 | 0 | 0 | 59% |
Price targets
Where 5 covering analysts think MRVI trades over the next 12 months.
$7.60 -3.8% upside Hold
Current$7.90 Low$7.00 Median$8.00 High$8.00 5 analysts
$7.00$8.00
Analyst rating Buy· 2.0/5 as of Oct 2, 2026
Reports & filings
AI-scored summaries of recent SEC filings and press releases, with sentiment and impact.
4 SEC filing reports analyzed · 1 bullish, 0 bearish, 2 mixed, 1 neutral · avg impact 4.3/10.
MIXEDINST-CLUSTER4/10
During Q1 2026, six institutional investors increased their MRVI positions (net +$2.3M) while three
Jun 14, 2026
BULLISH8-K6/10
Maravai LifeSciences refinanced its prior credit agreement by entering into a new $150.0 million ter
Jun 3, 2026
NEUTRALDEFA14A1/10
Maravai LifeSciences Holdings, Inc. filed a DEFA14A to add Inline XBRL tagging to its definitive pro
Apr 28, 2026
MIXED8-K6/10
Maravai LifeSciences reported full-year 2025 revenue of $185.7 million, down 28.3% year-over-year, d
Feb 25, 2026
Upcoming & catalyst events
Scheduled dates plus disclosed catalysts — earnings, dividends, enforcement, FDA and clinical-trial events. Colored dot = impact.
Aug 10, 2026
short_volume
Short Volume: MRVI — 71.5% short (0.5M / 0.6M)
Short: 451,752 | Exempt: 3,930 | TRF Vol: 631,871 | Short Ratio: 71.5% | Off-exchange volume (dark pool + OTC)
Aug 7, 2026
short_volume
Short Volume: MRVI — 61.7% short (0.8M / 1.4M)
Short: 835,870 | Exempt: 44,532 | TRF Vol: 1,354,150 | Short Ratio: 61.7% | Off-exchange volume (dark pool + OTC)
Aug 6, 2026
earnings_calendar
MRVI Q2 2026 Earnings After Market Close — 2026-08-06
Jul 21, 2026
short_volume
Short Volume: MRVI — 55.8% short (0.7M / 1.3M)
Short: 746,752 | Exempt: 29 | TRF Vol: 1,338,953 | Short Ratio: 55.8% | Off-exchange volume (dark pool + OTC)
Jul 16, 2026
short_volume
Short Volume: MRVI — 55.4% short (1.1M / 1.9M)
Short: 1,072,508 | Exempt: 5,108 | TRF Vol: 1,935,115 | Short Ratio: 55.4% | Off-exchange volume (dark pool + OTC)
Earnings estimates
Forecast earnings per share and revenue by period — and whether estimates are rising.
| Period | EPS Est. | Range | Growth | 30d Rev | Up/Dn | Revenue | # |
|---|---|---|---|---|---|---|---|
| Current Q | $-0.06 | $-0.08–$-0.04 | 30.9% | +39.0% | 2↑ 4↓ | $0.0B | 8 |
| Next Q | $-0.04 | $-0.07–$-0.03 | -8.1% | +48.4% | 0↑ 5↓ | $0.1B | 7 |
| Current FY | $-0.11 | $-0.15–$-0.08 | 63.5% | +41.5% | 6↑ 2↓ | $0.2B | 8 |
| Next FY | $-0.10 | $-0.20–$-0.02 | 7.1% | +2.1% | 4↑ 2↓ | $0.2B | 8 |
Current-quarter EPS estimate — revision history
| When | EPS estimate | Change vs now |
|---|---|---|
| Current | $-0.055 | — |
| 7d ago | $-0.089 | +0.034 |
| 30d ago | $-0.091 | +0.035 |
| 60d ago | $-0.046 | -0.009 |
| 90d ago | $-0.046 | -0.009 |
Institutional ownership
Which big funds own MRVI (from quarterly 13F filings) and who is adding or trimming.
50 institutional holders with $492.3M total value (78,827,970 shares) as of 2026-Q2. Top holders: BlackRock,, MILLENNIUM, VANGUARD. Net buying activity: 24 institutions added/increased vs 11 reduced.
Top holders — 2026-Q2
| Fund | Shares | Value | % Tracked | Last move |
|---|---|---|---|---|
| BlackRock, Inc. | 9,970,780 | $62.2M | 12.6% | — |
| MILLENNIUM MANAGEMENT LLC | 6,508,220 | $40.6M | 8.2% | DOUBLED +294.6% |
| VANGUARD CAPITAL MANAGEMENT LLC | 5,283,665 | $33.0M | 6.7% | — |
| RENAISSANCE TECHNOLOGIES LLC | 4,606,491 | $28.7M | 5.8% | — |
| DEUTSCHE BANK AG\ | 4,304,927 | $26.9M | 5.5% | DOUBLED +401.6% |
| First Eagle Investment Management, LLC | 3,671,287 | $22.9M | 4.7% | ADD +45.4% |
| GEODE CAPITAL MANAGEMENT, LLC | 3,130,258 | $19.5M | 4.0% | — |
| STATE STREET CORP | 2,901,706 | $18.1M | 3.7% | — |
| Nuveen, LLC | 2,857,580 | $17.8M | 3.6% | DOUBLED +1141.6% |
| JPMORGAN CHASE & CO | 2,593,559 | $16.6M | 3.4% | DOUBLED +626.0% |
Recent position changes
| Fund | Action | Prev | Current | Change | Value |
|---|---|---|---|---|---|
| MILLENNIUM MANAGEMENT LLC | DOUBLED | 1,649,490 | 6,508,220 | +294.6% | $40.6M |
| DEUTSCHE BANK AG\ | DOUBLED | 858,255 | 4,304,927 | +401.6% | $26.9M |
| First Eagle Investment Management, LLC | ADD | 2,524,336 | 3,671,287 | +45.4% | $22.9M |
| Nuveen, LLC | DOUBLED | 230,147 | 2,857,580 | +1141.6% | $17.8M |
| JPMORGAN CHASE & CO | DOUBLED | 357,260 | 2,593,559 | +626.0% | $16.6M |
| PRUDENTIAL FINANCIAL INC | DOUBLED | 18,470 | 2,152,154 | +11552.2% | $13.4M |
| CITADEL ADVISORS LLC | ADD | 1,484,319 | 2,122,598 | +43.0% | $13.2M |
| Point72 Asset Management, L.P. | TRIM | 3,205,496 | 2,005,579 | -37.4% | $12.5M |
| MORGAN STANLEY | TRIM | 3,319,325 | 1,908,276 | -42.5% | $11.9M |
| TUDOR INVESTMENT CORP ET AL | DOUBLED | 396,915 | 1,849,079 | +365.9% | $11.5M |
Insider activity
Buying and selling by company executives and directors (SEC Form 4).
11 insiders, 23 transactions. Net -$254.0K — $0.00 bought, $254.0K sold.
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 30, 2026 | Asarpota Rajesh | Chief Financial Officer | TAX W/H | 5,465 | $7.65 | $41.8K |
| Sep 8, 2026 | Brust Bernd | Chief Executive Officer | TAX W/H | 29,250 | $7.32 | $214.1K |
| Aug 31, 2026 | Asarpota Rajesh | Chief Financial Officer | TAX W/H | 5,465 | $7.68 | $42.0K |
| Aug 10, 2026 | Brust Bernd | Chief Executive Officer | TAX W/H | 29,250 | $6.23 | $182.2K |
| Jul 30, 2026 | Asarpota Rajesh | Chief Financial Officer | TAX W/H | 5,465 | $6.59 | $36.0K |
| Jul 8, 2026 | Brust Bernd | Chief Executive Officer | TAX W/H | 29,250 | $5.92 | $173.2K |
| Jun 30, 2026 | Asarpota Rajesh | Chief Financial Officer | TAX W/H | 65,584 | $6.39 | $419.1K |
| Jun 10, 2026 | ORESHACK KURT | General Counsel | SELL | 25,000 | $5.10 | $127.5K |
| Jun 9, 2026 | ORESHACK KURT | General Counsel | SELL | 25,000 | $5.06 | $126.5K |
| Jun 9, 2026 | LUCIER GREGORY T | Director | GIFT | 46,293 | — | — |
Short interest & halts
FINRA semi-monthly short positions, Reg SHO threshold status, and recent trading halts for MRVI.
Shares short
12,372,302
Settlement Sep 15, 2026
Change vs prior
+12.8%
Semi-monthly cycle
Days to cover
4.7
At avg daily volume
Of shares outstanding
≈4.8%
Estimate — not % of float
All MRVI filing & press-release reports (4)
- INST-CLUSTER reportJun 14, 2026
- 8-K reportJun 3, 2026
- DEFA14A reportApr 28, 2026
- 8-K reportFeb 25, 2026